Kwon J, Vera R, Fernandez-Zapico M
Cell Signal. 2025; 127:111584.
PMID: 39756502
PMC: 11807759.
DOI: 10.1016/j.cellsig.2024.111584.
Wang J, Yang J, Narang A, He J, Wolfgang C, Li K
J Hematol Oncol. 2024; 17(1):92.
PMID: 39390609
PMC: 11468220.
DOI: 10.1186/s13045-024-01613-x.
You E, Danaher P, Lu C, Sun S, Zou L, Phillips I
Cell. 2024; 187(25):7232-7247.e23.
PMID: 39383862
PMC: 11645244.
DOI: 10.1016/j.cell.2024.09.024.
Prattico F, Garajova I
Curr Oncol. 2024; 31(8):4241-4260.
PMID: 39195299
PMC: 11352508.
DOI: 10.3390/curroncol31080316.
Lamson D, Tarpley M, Addo K, Ji X, Abu Rabe D, Ehe B
Biochim Biophys Acta Gen Subj. 2024; 1868(11):130692.
PMID: 39151833
PMC: 11486593.
DOI: 10.1016/j.bbagen.2024.130692.
KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic Adenocarcinoma.
Than M, OHara M, Stanger B, Reiss K
Mol Cancer Ther. 2024; 23(10):1378-1388.
PMID: 39118358
PMC: 11444872.
DOI: 10.1158/1535-7163.MCT-23-0519.
LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance.
Huang Y, Zhang R, Lyu H, Xiao S, Guo D, Chen X
Int J Biol Sci. 2024; 20(7):2698-2726.
PMID: 38725864
PMC: 11077374.
DOI: 10.7150/ijbs.91832.
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging.
Saude-Conde R, Arcay Ozturk A, Stosic K, Azurmendi Senar O, Navez J, Bouchart C
Biomedicines. 2024; 12(3).
PMID: 38540204
PMC: 10968082.
DOI: 10.3390/biomedicines12030591.
Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer.
Wang M, Xue W, Yuan H, Wang Z, Yu L
Int J Nanomedicine. 2024; 19:2823-2849.
PMID: 38525013
PMC: 10959015.
DOI: 10.2147/IJN.S451151.
Tumor cell stemness in gastrointestinal cancer: regulation and targeted therapy.
Yang K, Yi T
Front Mol Biosci. 2024; 10:1297611.
PMID: 38455361
PMC: 10918437.
DOI: 10.3389/fmolb.2023.1297611.
Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors.
Roy Chaudhuri T, Lin Q, Stachowiak E, Rosario S, Spernyak J, Ma W
Clin Cancer Res. 2024; 30(7):1367-1381.
PMID: 38270582
PMC: 11019863.
DOI: 10.1158/1078-0432.CCR-23-0131.
Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression.
Hasselluhn M, Decker-Farrell A, Vlahos L, Thomas D, Curiel-Garcia A, Maurer H
Cancer Discov. 2023; 14(2):348-361.
PMID: 37966260
PMC: 10922937.
DOI: 10.1158/2159-8290.CD-23-0240.
Primary cilia: a novel research approach to overcome anticancer drug resistance.
Lee K
Front Mol Biosci. 2023; 10:1270639.
PMID: 37900915
PMC: 10602908.
DOI: 10.3389/fmolb.2023.1270639.
Integrated PK/PD Modeling Relates Smoothened Inhibitor Biomarkers to The Heterogeneous Intratumor Disposition of Cetuximab in Pancreatic Cancer Tumor Models.
Wang J, Chen T, Ruszaj D, Mager D, Straubinger R
J Pharm Sci. 2023; 113(1):72-84.
PMID: 37844759
PMC: 11706246.
DOI: 10.1016/j.xphs.2023.10.019.
Fibroblast subtypes in pancreatic cancer and pancreatitis: from mechanisms to therapeutic strategies.
Huang H, Lu W, Zhang X, Pan J, Cao F, Wen L
Cell Oncol (Dordr). 2023; 47(2):383-396.
PMID: 37721678
DOI: 10.1007/s13402-023-00874-x.
Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer.
De Grandis M, Ascenti V, Lanza C, Di Paolo G, Galassi B, Ierardi A
Int J Mol Sci. 2023; 24(16).
PMID: 37628865
PMC: 10454061.
DOI: 10.3390/ijms241612681.
An agarose-alginate microfluidic device for the study of spheroid invasion, ATRA inhibits CAFs-mediated matrix remodeling.
Nasiraee M, Shahrivari S, Sayad S, Mahdavi H, Saraygord-Afshari N, Bagheri Z
Cytotechnology. 2023; 75(4):309-323.
PMID: 37389131
PMC: 10299977.
DOI: 10.1007/s10616-023-00578-y.
The emerging roles of Hedgehog signaling in tumor immune microenvironment.
Wang J, Cui B, Li X, Zhao X, Huang T, Ding X
Front Oncol. 2023; 13:1171418.
PMID: 37213270
PMC: 10196179.
DOI: 10.3389/fonc.2023.1171418.
A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma.
Liu Q, Li R, Wu H, Liang Z
BMC Cancer. 2023; 23(1):226.
PMID: 36894917
PMC: 9999523.
DOI: 10.1186/s12885-023-10678-9.
Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment.
Tanaka H, Nakazawa T, Enomoto A, Masamune A, Kano M
Cancers (Basel). 2023; 15(3).
PMID: 36765684
PMC: 9913712.
DOI: 10.3390/cancers15030724.